SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-041930
Filing Date
2020-12-10
Accepted
2020-12-10 08:19:18
Documents
4
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea131388-6k_purplebiotech.htm 6-K 16154
2 PRESS RELEASE ea131388ex99-1_purplebiotech.htm EX-99.1 13907
3 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF KITOV PHARMA LTD ea131388ex99-2_purplebiotech.htm EX-99.2 305188
4 AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF KITOV PHARMA LTD ea131388ex99-3_purplebiotech.htm EX-99.3 8721
  Complete submission text file 0001213900-20-041930.txt   345148
Mailing Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101
Business Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101 97239333121
Kitov Pharma Ltd. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 201379534
SIC: 2834 Pharmaceutical Preparations